IFIRMACOMBI

This brand name is authorized in Albania, Austria, Croatia, Estonia, France, Ireland, Italy, Lithuania, Poland, Romania, Spain.

Active ingredients

The drug IFIRMACOMBI contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII 3OGC31WUMZ - IRBESARTAN HYDROCHLORIDE
 

Irbesartan is a potent, orally active, selective angiotensin-II receptor (type AT1) antagonist. It is expected to block all actions of angiotensin-II mediated by the AT1 receptor, regardless of the source or route of synthesis of angiotensin-II. The selective antagonism of the angiotensin-II (AT1) receptors results in increases in plasma renin levels and angiotensin-II levels, and a decrease in plasma aldosterone concentration.

 
Read more about Irbesartan
2
UNII 0J48LPH2TH - HYDROCHLOROTHIAZIDE
 

Hydrochlorothiazide is a diuretic with antihypertensive properties. It acts by inhibiting the renal tubular re-absorption of sodium and chloride ions, which are excreted with an accompanying volume of water. Potassium excretion is also promoted.

 
Read more about Hydrochlorothiazide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
C09DA04 Irbesartan and diuretics C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09D Angiotensin II antagonists, combinations → C09DA Angiotensin II antagonists and diuretics
Discover more medicines within C09DA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
AL Fondi i Sigurimit të Detyrueshëm të Kujdesit Shëndetësor 566/73, 568/73
EE Ravimiamet 1518915, 1518926, 1518937, 1518948, 1518959, 1518960, 1518971, 1518982, 1518993, 1519006, 1519017, 1519028, 1519039, 1519040, 1519051, 1519062, 1519073, 1519084, 1519095, 1519107, 1519118
ES Centro de información online de medicamentos de la AEMPS 11673002, 11673010, 11673018
FR Base de données publique des médicaments 64018107, 65355223, 66500369
IE Health Products Regulatory Authority 19630, 19671, 19723
IT Agenzia del Farmaco 041633025, 041633102, 041633189
LT Valstybinė vaistų kontrolės tarnyba 1059557, 1059558, 1059559, 1059560, 1059561, 1059562, 1059563, 1059564, 1059565, 1059566, 1059567, 1059568, 1059569, 1059570, 1059571, 1059572, 1059573, 1059574, 1059575, 1059576, 1059577, 1059578, 1059579, 1059580
PL Rejestru Produktów Leczniczych 100310619, 100310631, 100310648
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W57419001, W57419002, W57419003, W57419004, W57419005, W57419006, W57419007, W57419008, W57420001, W57420002, W57420003, W57420004, W57420005, W57420006, W57420007, W57420008, W57421001, W57421002, W57421003, W57421004, W57421005, W57421006, W57421007, W57421008

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.